Genomically encoded lineage plasticity drives resistance to EGFR targeted therapy in lung adenocarcinoma

被引：0
|
作者：
Zatzman, Matthew
Quintanal-Villalonga, Alvaro
Salehi, Sohrab
Falcon, Christina
Ceglia, Nicholas
Shah, Sohrab P.
Rudin, Charles M.
Yu, Helena A.
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-1226
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1226
引用
收藏
页数：2
相关论文
共 50 条
  • [1] SCLC Lineage Transformation in Lung Adenocarcinoma and Resistance to Targeted Therapies
    Lockwood, W.
    Inoue, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S40 - S40
  • [2] Lung adenocarcinoma: guiding EGFR-targeted therapy and beyond
    Ladanyi, Marc
    Pao, William
    MODERN PATHOLOGY, 2008, 21 : S16 - S22
  • [3] FGA isoform as an indicator of targeted therapy for EGFR mutated lung adenocarcinoma
    Shang, Zhi
    Niu, Xiaomin
    Zhang, Kewei
    Qiao, Zhi
    Liu, Sha
    Jiang, Xiaoteng
    Cao, Chengxi
    Lu, Shun
    Xiao, Hua
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2019, 97 (12): : 1657 - 1668
  • [4] FGA isoform as an indicator of targeted therapy for EGFR mutated lung adenocarcinoma
    Zhi Shang
    Xiaomin Niu
    Kewei Zhang
    Zhi Qiao
    Sha Liu
    Xiaoteng Jiang
    Chengxi Cao
    Shun Lu
    Hua Xiao
    Journal of Molecular Medicine, 2019, 97 : 1657 - 1668
  • [5] Understanding Lineage Plasticity as a Path to Targeted Therapy Failure in EGFR-Mutant Non-small Cell Lung Cancer
    Shaurova, Tatiana
    Zhang, Letian
    Goodrich, David W.
    Hershberger, Pamela A.
    FRONTIERS IN GENETICS, 2020, 11
  • [6] The TLE1 transcriptional and epigenetic machinery contributes to EGFR targeted therapy resistance in human lung adenocarcinoma
    Biliran, Hector Ramos
    Yao, Xin
    Roberts, Nasir
    Iheukwumere, Prince
    Chen, Renwei
    Dela Cruz, Ma. Carmela
    CANCER RESEARCH, 2024, 84 (06)
  • [7] cfDNA changes for monitoring of targeted therapy in a primary EGFR mutation lung adenocarcinoma
    He, Qiong
    Zhu, Xian
    Shi, Xun
    Lin, Chen
    Jin, Yin
    Yan, Junrong
    He, Jiachen
    Yu, Xinmin
    TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (03) : 807 - 810
  • [8] Classification of EGFR mutations in Pakistani lung adenocarcinoma for predicting response to targeted therapy
    Ahmed, Z. A.
    Pervez, S.
    Moatter, T.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S107 - S107
  • [9] Mechanisms of primary resistance to EGFR targeted therapy in advanced lung adenocarcinomas
    Jin, Ying
    Shi, Xun
    Zhao, Jun
    He, Qiong
    Chen, Ming
    Yan, Junrong
    Ou, Qiuxiang
    Wu, Xue
    Shao, Yang W.
    Yu, Xinmin
    LUNG CANCER, 2018, 124 : 110 - 116
  • [10] CHD-loss promotes tumor heterogeneity, lineage plasticity and resistance to AR targeted therapy resistance
    Mu, P.
    EUROPEAN JOURNAL OF CANCER, 2020, 138 : S22 - S23
12345